News summary

SIRONA 3-Year Results: Sirolimus-Coated Balloon Shows Higher Freedom From Repeat Revascularization Than Paclitaxel-Coated Balloons in Femoropopliteal Disease

Source: PR Newswire • Published: 03 Nov 2026, 10:27

Summarized by Masters of Longevity from PR Newswire.

In SIRONA, sirolimus-coated balloons had higher three‑year freedom from cdTLR than paclitaxel.

SIRONA 3-Year Results: Sirolimus-Coated Balloon Shows Higher Freedom From Repeat Revascularization Than Paclitaxel-Coated Balloons in Femoropopliteal Disease
Key Takeaways
  • Sirolimus showed eight percentage points greater freedom from cdTLR.
  • Walking distance and quality of life were similar between groups.
  • The cdTLR difference is exploratory and needs longer confirmation.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickPlan Your Health Tests in Three MinutesThe free Personal Health Diagnostics Planner turns a short questionnaire into a ranked, personalised PDF: a clearer starting point for deciding which health checks deserve attention now.MoL PickCan Exergaming Improve Balance? What Older Adults Should KnowMotion-controlled games may make balance practice easier to repeat. The evidence supports a structured adjunct—not a fall-proofing shortcut.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?